These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

383 related items for PubMed ID: 3292562

  • 1. Resumption of puberty after long term luteinizing hormone-releasing hormone agonist treatment of central precocious puberty.
    Manasco PK, Pescovitz OH, Feuillan PP, Hench KD, Barnes KM, Jones J, Hill SC, Loriaux DL, Cutler GB.
    J Clin Endocrinol Metab; 1988 Aug; 67(2):368-72. PubMed ID: 3292562
    [Abstract] [Full Text] [Related]

  • 2. Adult height in precocious puberty after long-term treatment with deslorelin.
    Oerter KE, Manasco P, Barnes KM, Jones J, Hill S, Cutler GB.
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1235-40. PubMed ID: 1955504
    [Abstract] [Full Text] [Related]

  • 3. Treatment of true precocious puberty with a potent luteinizing hormone-releasing factor agonist: effect on growth, sexual maturation, pelvic sonography, and the hypothalamic-pituitary-gonadal axis.
    Styne DM, Harris DA, Egli CA, Conte FA, Kaplan SL, Rivier J, Vale W, Grumbach MM.
    J Clin Endocrinol Metab; 1985 Jul; 61(1):142-51. PubMed ID: 3923027
    [Abstract] [Full Text] [Related]

  • 4. Somatomedin-C in normal puberty and in true precocious puberty before and after treatment with a potent luteinizing hormone-releasing hormone agonist.
    Harris DA, Van Vliet G, Egli CA, Grumbach MM, Kaplan SL, Styne DM, Vainsel M.
    J Clin Endocrinol Metab; 1985 Jul; 61(1):152-9. PubMed ID: 3889035
    [Abstract] [Full Text] [Related]

  • 5. Luteinizing hormone releasing hormone analogue therapy for central precocious puberty. Long-term effect on somatic growth, bone maturation, and predicted height.
    Comite F, Cassorla F, Barnes KM, Hench KD, Dwyer A, Skerda MC, Loriaux DL, Cutler GB, Pescovitz OH.
    JAMA; 1986 May 16; 255(19):2613-6. PubMed ID: 3084811
    [Abstract] [Full Text] [Related]

  • 6. Effect of deslorelin dose in the treatment of central precocious puberty.
    Pescovitz OH, Barnes KM, Cutler GB.
    J Clin Endocrinol Metab; 1991 Jan 16; 72(1):60-4. PubMed ID: 1898743
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Long-term treatment of central precocious puberty with a long-acting analogue of luteinizing hormone-releasing hormone. Effects on somatic growth and skeletal maturation.
    Mansfield MJ, Beardsworth DE, Loughlin JS, Crawford JD, Bode HH, Rivier J, Vale W, Kushner DC, Crigler JF, Crowley WF.
    N Engl J Med; 1983 Nov 24; 309(21):1286-90. PubMed ID: 6415479
    [Abstract] [Full Text] [Related]

  • 10. True precocious puberty complicating congenital adrenal hyperplasia: treatment with a luteinizing hormone-releasing hormone analog.
    Pescovitz OH, Comite F, Cassorla F, Dwyer AJ, Poth MA, Sperling MA, Hench K, McNemar A, Skerda M, Loriaux DL.
    J Clin Endocrinol Metab; 1984 May 24; 58(5):857-61. PubMed ID: 6368580
    [Abstract] [Full Text] [Related]

  • 11. Variable response to a long-acting agonist of luteinizing hormone-releasing hormone in girls with McCune-Albright syndrome.
    Foster CM, Comite F, Pescovitz OH, Ross JL, Loriaux DL, Cutler GB.
    J Clin Endocrinol Metab; 1984 Oct 24; 59(4):801-5. PubMed ID: 6434582
    [Abstract] [Full Text] [Related]

  • 12. Increased final height in precocious puberty after long-term treatment with LHRH agonists: the National Institutes of Health experience.
    Klein KO, Barnes KM, Jones JV, Feuillan PP, Cutler GB.
    J Clin Endocrinol Metab; 2001 Oct 24; 86(10):4711-6. PubMed ID: 11600530
    [Abstract] [Full Text] [Related]

  • 13. Use of a potent, long acting agonist of gonadotropin-releasing hormone in the treatment of precocious puberty.
    Boepple PA, Mansfield MJ, Wierman ME, Rudlin CR, Bode HH, Crigler JF, Crawford JD, Crowley WF.
    Endocr Rev; 1986 Feb 24; 7(1):24-33. PubMed ID: 2937629
    [Abstract] [Full Text] [Related]

  • 14. Long term treatment of male and female precocious puberty by periodic administration of a long-acting preparation of D-Trp6-luteinizing hormone-releasing hormone microcapsules.
    Roger M, Chaussain JL, Berlier P, Bost M, Canlorbe P, Colle M, Francois R, Garandeau P, Lahlou N, Morel Y.
    J Clin Endocrinol Metab; 1986 Apr 24; 62(4):670-7. PubMed ID: 2936759
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effect of deslorelin-induced pubertal delay on the growth of adolescents with short stature and normally timed puberty: preliminary results.
    Municchi G, Rose SR, Pescovitz OH, Barnes KM, Cassorla FG, Cutler GB.
    J Clin Endocrinol Metab; 1993 Nov 24; 77(5):1334-9. PubMed ID: 8077329
    [Abstract] [Full Text] [Related]

  • 18. Luteinizing hormone-releasing hormone analog treatment of boys with hypothalamic hamartoma and true precocious puberty.
    Comite F, Pescovitz OH, Rieth KG, Dwyer AJ, Hench K, McNemar A, Loriaux DL, Cutler GB.
    J Clin Endocrinol Metab; 1984 Nov 24; 59(5):888-92. PubMed ID: 6434587
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.